SureTrader
Interactive Brokers Advertisement
Home > Boards > Canadian > Biotechs > Nuvo Research Inc. (TSX:NRI)

ST. LOUIS and MISSISSAUGA, ON, Aug. 4 /CNW/

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
AC416 Member Profile
 
Followed By 30
Posts 3,022
Boards Moderated 0
Alias Born 09/29/06
160x600 placeholder
Nuvo Pharmaceuticals™ Announces 2017 Third Quarter Results "PR Newswire (Canada)" - 11/1/2017 5:00:00 PM
Nuvo Pharmaceuticals™ Announces 2017 Third Quarter Results "PR Newswire (US)" - 11/1/2017 5:00:00 PM
Nuvo Pharmaceuticals™ Secures Credit Facility from the Royal Bank of Canada "PR Newswire (Canada)" - 8/24/2017 7:30:00 AM
Nuvo Pharmaceuticals™ Secures Credit Facility from the Royal Bank of Canada "PR Newswire (US)" - 8/24/2017 7:30:00 AM
Nuvo Pharmaceuticals™ Announces 2017 Second Quarter Results "PR Newswire (Canada)" - 8/9/2017 5:00:00 PM
Nuvo Pharmaceuticals™ Announces 2017 Second Quarter Results "PR Newswire (US)" - 8/9/2017 5:00:00 PM
Nuvo Pharmaceuticals™ Inc. Announces Topline Results from European Ankle Sprain Study with Pennsaid® 2% "PR Newswire (Canada)" - 5/15/2017 7:36:00 AM
Nuvo Pharmaceuticals™ Inc. Announces Topline Results from European Ankle Sprain Study with Pennsaid® 2% "PR Newswire (US)" - 5/15/2017 7:36:00 AM
Nuvo Pharmaceuticals™ Announces District Court Decision to Uphold U.S. Pennsaid® 2% Patent "PR Newswire (Canada)" - 5/15/2017 7:30:00 AM
Nuvo Pharmaceuticals™ Announces District Court Decision to Uphold U.S. Pennsaid® 2% Patent "PR Newswire (US)" - 5/15/2017 7:30:00 AM
Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting "PR Newswire (Canada)" - 5/11/2017 5:02:00 PM
Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting "PR Newswire (US)" - 5/11/2017 5:02:00 PM
Nuvo Pharmaceuticals™ Announces 2017 First Quarter Results "PR Newswire (Canada)" - 5/10/2017 5:00:00 PM
Nuvo Pharmaceuticals™ Announces 2017 First Quarter Results "PR Newswire (US)" - 5/10/2017 5:00:00 PM
Nuvo Pharmaceuticals™ Enters into Pennsaid® 2% License Agreement with Sayre Therapeutics PVT Ltd. for India, Sri Lanka, Ba... "PR Newswire (Canada)" - 3/28/2017 7:30:00 AM
Nuvo Pharmaceuticals™ Enters into Pennsaid® 2% License Agreement with Sayre Therapeutics PVT Ltd. for India, Sri Lanka, Ba... "PR Newswire (US)" - 3/28/2017 7:30:00 AM
Nuvo Pharmaceuticals™ Announces 2016 Year-End and Fourth Quarter Results "PR Newswire (Canada)" - 3/1/2017 5:00:00 PM
Nuvo Pharmaceuticals™ Announces 2016 Year-End and Fourth Quarter Results "PR Newswire (US)" - 3/1/2017 5:00:00 PM
AC416   Tuesday, 08/04/09 10:52:08 PM
Re: None
Post # of 83 
ST. LOUIS and MISSISSAUGA, ON, Aug. 4 /CNW/ - Covidien (NYSE:COV - News), a leading global provider of healthcare products, and Nuvo Research Inc. (TSX:NRI - News), a Canadian drug development company, today announced that the U.S. Food and Drug Administration (FDA) has set a new action date under the Prescription Drug User Fee Act (PDUFA) for Pennsaid (diclofenac sodium) topical solution 1.5% w/w of November 4, 2009.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist